What is Pharma Matrix?
Established in 2004, Pharma Matrix operates as a comprehensive service provider specializing in Pharmaceutical Engineering, Commissioning, Project Management, Quality Assurance, and Validation Services. The firm has cultivated a strong presence across North Carolina, South Carolina, Virginia, Pennsylvania, and Maryland, distinguishing itself through a client-centric approach that emphasizes tailored solutions and technical precision.
The company's market position is defined by its ability to adapt to the evolving needs of the pharmaceutical industry, integrating the latest technological advancements into its service delivery model. By prioritizing deep integration with client operations, Pharma Matrix ensures that its engineering and validation workflows meet the rigorous demands of modern drug manufacturing and development environments.
How much funding has Pharma Matrix raised?
Pharma Matrix has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Pharma Matrix
PPP
Public-Private Partnership
What's next for Pharma Matrix?
With the successful closure of this late-stage funding, Pharma Matrix is poised to enter a new phase of strategic growth. The company intends to utilize this capital to scale its service offerings and enhance its technical infrastructure, further cementing its role as an essential partner for pharmaceutical manufacturers navigating complex regulatory landscapes.
Future initiatives will likely focus on expanding the firm's geographic reach and deepening its expertise in emerging pharmaceutical technologies. By maintaining its focus on superior customer relations and operational excellence, Pharma Matrix is set to capitalize on the increasing demand for high-quality validation and commissioning services, ensuring sustained value creation for its stakeholders and clients alike.
